Relationship between response to risperidone, plasma concentrations of risperidone and CYP3A4 polymorphisms in schizophrenia patients

被引：28
|
作者：
Du, J.
Zhang, A. [1 ]
Wang, L. [1 ]
Xuan, J. [1 ]
Yu, L. [1 ]
Che, R. [1 ]
Li, X. [1 ]
Gu, N. [3 ]
Lin, Z. [3 ]
Feng, G. [3 ]
Xing, Q. [1 ]
He, L. [1 ,2 ]
机构：
[1] Chinese Acad Sci, Inst Nutr Sci, SIBS, Shanghai 200031, Peoples R China
[2] Shanghai Jiao Tong Univ, Bio X Ctr, NHGG, Shanghai 200030, Peoples R China
[3] Shanghai Inst Mental Hlth, Shanghai, Peoples R China
来源：
JOURNAL OF PSYCHOPHARMACOLOGY | 2010年 / 24卷 / 07期
基金：
中国国家自然科学基金;
关键词：
9-hydroxyrisperidone; clinical response; CYP3A4; risperidone; schizophrenia; ANTIPSYCHOTIC-DRUGS; METABOLISM; RELAPSE; CYP2D6; PREVENTION; POOR; 2D6;
D O I：
10.1177/0269881109104932
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
In this study, we examined the relationships between plasma concentrations of risperidone and 9-hydroxyrisperidone and polymorphisms of CYP3A4. All 130 schizophrenia patients (45 men, 85 women, age 15-60 years) who met DSM-IV criteria were given risperidone for 8 weeks. Clinical efficacy was determined using the Positive and Negative Syndrome Scale (PANSS). CYP3A4*1G was found to be associated with the change in total PANSS scores (Kruskal-Wallis test, P = 0.021), which was not significant on adjusting for multiple testing. Our study has, for the first time, conducted a genetic association study of the CYP3A4 gene with risperidone response. Further studies on larger groups and on the effects of the longer term risperidone treatment are needed to confirm these results.
引用
收藏
页码：1115 / 1120
页数：6
相关论文
共 50 条
  • [1] Relationship between plasma risperidone and 9-hydroxyrisperidone concentrations and clinical response in patients with schizophrenia
    Edoardo Spina
    Angela Avenoso
    Gabriella Facciolà
    Monica Salemi
    Maria G. Scordo
    Maria Ancione
    Aldo G. Madia
    Emilio Perucca
    Psychopharmacology, 2001, 153 : 238 - 243
  • [2] Relationship between plasma risperidone and 9-hydroxyrisperidone concentrations and clinical response in patients with schizophrenia
    Spina, E
    Avenoso, A
    Facciolà, G
    Salemi, M
    Scordo, MG
    Ancione, M
    Madia, AG
    Perucca, E
    PSYCHOPHARMACOLOGY, 2001, 153 (02) : 238 - 243
  • [3] Effect of fluvoxamine on plasma risperidone concentrations in patients with schizophrenia
    D'Arrigo, C
    Migliardi, G
    Santoro, V
    Morgante, L
    Muscatello, MR
    Ancione, M
    Spina, E
    PHARMACOLOGICAL RESEARCH, 2005, 52 (06) : 497 - 501
  • [4] Relationship between risperidone and 9-hydroxy-risperidone plasma concentrations and CYP2D6 enzyme activity in psychiatric patients
    Berecz, R
    Llerena, A
    de la Rubia, A
    Gómez, J
    Kellermann, M
    Dorado, P
    Degrell, I
    PHARMACOPSYCHIATRY, 2002, 35 (06) : 231 - 234
  • [5] The Influence of the CYP3A4*22 Polymorphism and CYP2D6 Polymorphisms on Serum Concentrations of Aripiprazole, Haloperidol, Pimozide, and Risperidone in Psychiatric Patients
    van der Weide, Karen
    van der Weide, Jan
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2015, 35 (03) : 228 - 236
  • [6] Relationship between plasma risperidone concentrations and clinical response in patients with first-episode psychosis
    Verma, S
    Tan, CH
    Chan, YH
    Chong, SA
    SCHIZOPHRENIA RESEARCH, 2004, 70 (01) : 144 - 144
  • [7] Risperidone and 9-OH-risperidone plasma levels and clinical response in schizophrenia patients
    Strassnig, MT
    Schwarz, MJ
    Spellmann, I
    Mueller-Arends, A
    Dehning, S
    Möller, HJ
    Mueller, N
    Riedel, M
    BIOLOGICAL PSYCHIATRY, 2004, 55 : 147S - 147S
  • [8] Relationship between plasma risperidone concentrations and clinical features in chronic schizophrenic patients in China
    Xu, Jing-Wen
    Guan, Xiao-Bo
    Wang, Xue-Ying
    Feng, Yang
    Zhang, Qi
    Zhu, Jun-Juan
    Chen, Jian-Hua
    WORLD JOURNAL OF PSYCHIATRY, 2024, 14 (04):
  • [9] Relationship between clinical efficacy and plasma concentration-dose ratio of risperidone in patients with schizophrenia
    Chen, Qiuying
    Min, Jie
    Yin, Haibo
    Xia, Wenying
    Shen, Yimin
    Shu, Ming
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2024, 39 (01) : 17 - 22
  • [10] The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions
    C Rafaniello
    M Sessa
    F F Bernardi
    M Pozzi
    S Cheli
    D Cattaneo
    S Baldelli
    M Molteni
    R Bernardini
    F Rossi
    E Clementi
    C Bravaccio
    S Radice
    A Capuano
    The Pharmacogenomics Journal, 2018, 18 : 422 - 430
12345